Bioassay for Tumor Necrosis Factors-alpha and -beta
- 1 January 2000
- journal article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 15 (3) , 243-248
- https://doi.org/10.1385/mb:15:3:243
Abstract
Tumor necrosis factor (TNF) is a central cytokine in the pathogenesis of septic shock and other inflammatory states. Assay by immunoassay is convenient, but, because of circulating soluble receptors, does not accurately reflect biological activity of the cytokine. This article describes how to perform a bioassay for TNF, using its cytopathic effect on the murine cell line L929. By suitable manipulation, the assay can determine the two different forms of TNF, alpha and beta.Keywords
This publication has 9 references indexed in Scilit:
- Detection of circulating bacterial superantigen and lymphotoxin-a in patients with streptococcal toxic-shock syndromeThe Lancet, 1996
- Lipopolysaccharide synergizes with tumour necrosis factor-alpha in cytotoxicity assays.1992
- A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factorsJournal of Immunological Methods, 1991
- Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factorCell, 1989
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityNature, 1984
- Comparison of in vitro cell cytotoxic assays for tumor necrosis factorJournal of Immunological Methods, 1984
- Endotoxin-Induced Tumor Necrosis FactorPublished by Springer Nature ,1980